Dublin, March 14, 2024 (GLOBE NEWSWIRE) -- The "Global In Vivo CRO Market by Type (Non-Rodent, Rodent), GLP Type (GLP Toxicology, Non-GLP), Indication - Forecast 2024-2030" report has been added to ResearchAndMarkets.com's offering.
The In Vivo CRO Market size was estimated at USD 4.46 billion in 2023, USD 4.87 billion in 2024, and is expected to grow at a CAGR of 9.75% to reach USD 8.56 billion by 2030. 
Market Share Analysis
The Market Share Analysis is a comprehensive tool that provides an insightful and in-depth examination of the current state of vendors in the In Vivo CRO Market. By meticulously comparing and analyzing vendor contributions in terms of overall revenue, customer base, and other key metrics, we can offer companies a greater understanding of their performance and the challenges they face when competing for market share. Additionally, this analysis provides valuable insights into the competitive nature of the sector, including factors such as accumulation, fragmentation dominance, and amalgamation traits observed over the base year period studied. With this expanded level of detail, vendors can make more informed decisions and devise effective strategies to gain a competitive edge in the market.
Key Company Profiles
The report delves into recent significant developments in the In Vivo CRO Market, highlighting leading vendors and their innovative profiles. These include Charles River Laboratories, Crown Bioscience, Inc., Eurofins Scientific SE, Evotec SE, ICON Plc, Labcorp Drug Development, Medpace, Inc., MI Bioresearch, Inc., Parexel International Corporation, Pharmacology Discovery Services, PPD Inc., Syneos Health, Syngene International Limited, Taconic Biosciences, Inc., and WuXi AppTec, Inc.
Market Segmentation & Coverage
This research report categorizes the In Vivo CRO Market to forecast the revenues and analyze trends in each of the following sub-markets:
- Type
- Non-Rodent
- Rodent
- Mice
- Rats
- GLP Type
- GLP Toxicology
- In House
- Outsourcing
- Non-GLP
- In House
- Outsourcing
- GLP Toxicology
- Indication
- Autoimmune/inflammation conditions
- Irritable Bowel Syndrome
- Multiple Sclerosis
- Osteoarthritis
- Rheumatoid Arthritis
- Blood Cancer
- CNS conditions
- ALS
- Epilepsy
- Huntington's Disease
- Muscle Regeneration
- Parkinson's Disease
- Stroke
- Traumatic Brain Injury
- Diabetes
- Obesity
- Oncology
- Pain management
- Acute Pain
- Chronic Pain
- Solid Tumor
- Patient-derived Xenograft
- Syngeneic Model
- Xenograft
- Autoimmune/inflammation conditions
For more information about this report visit https://www.researchandmarkets.com/r/jakkmg
About ResearchAndMarkets.com
ResearchAndMarkets.com is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.
Attachment
